NOGIN INC (NOGN) Fundamental Analysis & Valuation

NASDAQ:NOGN • US65528N2045

Current stock price

0.061 USD
-0.05 (-45.58%)
At close:
0.0526 USD
-0.01 (-13.77%)
After Hours:

This NOGN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. NOGN Profitability Analysis

1.1 Basic Checks

  • NOGN had negative earnings in the past year.
  • In the past year NOGN has reported a negative cash flow from operations.
NOGN Yearly Net Income VS EBIT VS OCF VS FCFNOGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 0 -20M -40M

1.2 Ratios

  • NOGN has a worse Return On Assets (-82.25%) than 97.06% of its industry peers.
Industry RankSector Rank
ROA -82.25%
ROE N/A
ROIC N/A
ROA(3y)-25.04%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NOGN Yearly ROA, ROE, ROICNOGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 0 200 -200 -400

1.3 Margins

  • NOGN's Gross Margin of 46.16% is fine compared to the rest of the industry. NOGN outperforms 61.76% of its industry peers.
  • In the last couple of years the Gross Margin of NOGN has declined.
  • The Profit Margin and Operating Margin are not available for NOGN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.25%
GM growth 5YN/A
NOGN Yearly Profit, Operating, Gross MarginsNOGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 0 20 -20 40 -40 60

0

2. NOGN Health Analysis

2.1 Basic Checks

  • NOGN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, NOGN has about the same amount of shares outstanding.
  • Compared to 1 year ago, NOGN has a worse debt to assets ratio.
NOGN Yearly Shares OutstandingNOGN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2M 4M 6M 8M 10M
NOGN Yearly Total Debt VS Total AssetsNOGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 20M 40M 60M

2.2 Solvency

  • NOGN has an Altman-Z score of -7.66. This is a bad value and indicates that NOGN is not financially healthy and even has some risk of bankruptcy.
  • NOGN has a worse Altman-Z score (-7.66) than 82.35% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.66
ROIC/WACCN/A
WACC4.56%
NOGN Yearly LT Debt VS Equity VS FCFNOGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 20M -20M 40M -40M 60M -60M

2.3 Liquidity

  • A Current Ratio of 0.14 indicates that NOGN may have some problems paying its short term obligations.
  • The Current ratio of NOGN (0.14) is worse than 97.06% of its industry peers.
  • NOGN has a Quick Ratio of 0.14. This is a bad value and indicates that NOGN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NOGN has a worse Quick ratio (0.06) than 97.06% of its industry peers.
Industry RankSector Rank
Current Ratio 0.14
Quick Ratio 0.06
NOGN Yearly Current Assets VS Current LiabilitesNOGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 10M 20M 30M 40M 50M

4

3. NOGN Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 25.81% over the past year.
  • The Revenue for NOGN has decreased by -39.39% in the past year. This is quite bad
  • The Revenue has been growing by 32.09% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)25.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-120.69%
Revenue 1Y (TTM)-39.39%
Revenue growth 3Y32.09%
Revenue growth 5YN/A
Sales Q2Q%-48.01%

3.2 Future

  • The Earnings Per Share is expected to grow by 26.11% on average over the next years. This is a very strong growth
  • NOGN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.87% yearly.
EPS Next Y88.6%
EPS Next 2Y41.4%
EPS Next 3Y26.11%
EPS Next 5YN/A
Revenue Next Year-42.53%
Revenue Next 2Y-10.49%
Revenue Next 3Y2.87%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NOGN Yearly Revenue VS EstimatesNOGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
NOGN Yearly EPS VS EstimatesNOGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 0 -10 -20 -30

1

4. NOGN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NOGN. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NOGN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NOGN Price Earnings VS Forward Price EarningsNOGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NOGN Per share dataNOGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as NOGN's earnings are expected to grow with 26.11% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.4%
EPS Next 3Y26.11%

0

5. NOGN Dividend Analysis

5.1 Amount

  • No dividends for NOGN!.
Industry RankSector Rank
Dividend Yield N/A

NOGN Fundamentals: All Metrics, Ratios and Statistics

NOGIN INC

NASDAQ:NOGN (12/21/2023, 8:00:02 PM)

After market: 0.0526 -0.01 (-13.77%)

0.061

-0.05 (-45.58%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)11-22
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners173.51%
Ins Owner Change0%
Market Cap688.60K
Revenue(TTM)68.27M
Net Income(TTM)-38.88M
Analysts42.86
Price Target1.02 (1572.13%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-55.76%
Min EPS beat(2)-88.42%
Max EPS beat(2)-23.09%
EPS beat(4)1
Avg EPS beat(4)-47.28%
Min EPS beat(4)-88.42%
Max EPS beat(4)0.72%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-9.96%
Min Revenue beat(2)-16.37%
Max Revenue beat(2)-3.55%
Revenue beat(4)0
Avg Revenue beat(4)-10.35%
Min Revenue beat(4)-19.37%
Max Revenue beat(4)-2.13%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-60%
PT rev (3m)-60%
EPS NQ rev (1m)0%
EPS NQ rev (3m)45.79%
EPS NY rev (1m)-7.04%
EPS NY rev (3m)-7.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.5%
Revenue NY rev (1m)1.91%
Revenue NY rev (3m)1.91%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-6.12
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-3.34
FCFYN/A
OCF(TTM)-3.28
OCFYN/A
SpS6.05
BVpS-8.46
TBVpS-8.93
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -82.25%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 46.16%
FCFM N/A
ROA(3y)-25.04%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.25%
GM growth 5YN/A
F-Score4
Asset Turnover1.44
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 65.24%
Cap/Sales 0.91%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.14
Quick Ratio 0.06
Altman-Z -7.66
F-Score4
WACC4.56%
ROIC/WACCN/A
Cap/Depr(3y)305.57%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.31%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-120.69%
EPS Next Y88.6%
EPS Next 2Y41.4%
EPS Next 3Y26.11%
EPS Next 5YN/A
Revenue 1Y (TTM)-39.39%
Revenue growth 3Y32.09%
Revenue growth 5YN/A
Sales Q2Q%-48.01%
Revenue Next Year-42.53%
Revenue Next 2Y-10.49%
Revenue Next 3Y2.87%
Revenue Next 5YN/A
EBIT growth 1Y-59.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year48.07%
EBIT Next 3Y34.2%
EBIT Next 5YN/A
FCF growth 1Y-21.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-24.43%
OCF growth 3YN/A
OCF growth 5YN/A

NOGIN INC / NOGN Fundamental Analysis FAQ

What is the fundamental rating for NOGN stock?

ChartMill assigns a fundamental rating of 1 / 10 to NOGN.


What is the valuation status for NOGN stock?

ChartMill assigns a valuation rating of 1 / 10 to NOGIN INC (NOGN). This can be considered as Overvalued.


Can you provide the profitability details for NOGIN INC?

NOGIN INC (NOGN) has a profitability rating of 1 / 10.


What is the expected EPS growth for NOGIN INC (NOGN) stock?

The Earnings per Share (EPS) of NOGIN INC (NOGN) is expected to grow by 88.6% in the next year.